After a years-long battle between the Sackler family and the Department of Justice, as well as a Netflix (NASDAQ:NFLX) series ...

Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to ...

OxyContin maker Purdue Pharma ’s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward ...

All 50 states agreed Monday to sign a settlement with Purdue Pharma, the company behind the highly addictive ... This settlement will need to be approved by a federal bankruptcy court before ...

Purdue Pharma received approval for the company's disclosure statement tied to its chapter 11 reorganization plan that aims to deliver more than $7.4 billion in cash to creditors to compensate victims ...

Oxycontin maker Purdue Pharma received court approval on Friday to begin voting on its $7.4 billion bankruptcy settlement, while deferring questions about how state and local governments should ...

All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.

OxyContin maker Purdue Pharma ‘s latest plan to settle thousands of lawsuits over the toll of ... The request of U.S. Bankruptcy Court Judge Sean Lane comes about a year after the U.S. Supreme ...

Maryland could get $90M from a $7.4B Purdue Pharma settlement over its role in the opioid crisis, pending approval from a bankruptcy court.

OxyContin maker Purdue Pharma ‘s $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will go before a judge Friday, potentially setting up votes on whether to accept it ...

The Supreme Court overturned a previous version of the Purdue Pharma-Sackler bankruptcy plan, leading to a new deal now under review. Updated June 16, 2025 at 2:45 PM EDT.